1. Home
  2. CLS vs IQV Comparison

CLS vs IQV Comparison

Compare CLS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celestica Inc.

CLS

Celestica Inc.

HOLD

Current Price

$311.40

Market Cap

32.5B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$222.91

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLS
IQV
Founded
1994
1982
Country
Canada
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.5B
36.4B
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
CLS
IQV
Price
$311.40
$222.91
Analyst Decision
Strong Buy
Buy
Analyst Count
13
17
Target Price
$308.77
$237.59
AVG Volume (30 Days)
3.1M
1.4M
Earning Date
01-28-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
103.66
N/A
EPS
6.15
7.30
Revenue
$11,281,700,000.00
$15,904,000,000.00
Revenue This Year
$27.66
$6.14
Revenue Next Year
$32.94
$5.35
P/E Ratio
$49.82
$30.43
Revenue Growth
22.09
3.85
52 Week Low
$58.05
$134.65
52 Week High
$363.40
$234.30

Technical Indicators

Market Signals
Indicator
CLS
IQV
Relative Strength Index (RSI) 47.56 51.22
Support Level $297.35 $220.65
Resistance Level $353.38 $226.77
Average True Range (ATR) 18.97 5.11
MACD -1.63 -1.10
Stochastic Oscillator 24.33 40.70

Price Performance

Historical Comparison
CLS
IQV

About CLS Celestica Inc.

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: